Graf Akcie RMD (Resmed Inc.). Diskuze k akciím RMD. Aktuální informace RMD.

Základní informace o společnosti Resmed Inc. (Akcie RMD)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 36.62B
Hodnota podniku (EV) 42.35B
Tržby 3.197B
EBITDA 977.351M
Zisk 474.505M
Růst v tržbách Q/Q 13.73 %
Růst v tržbách Y/Y 8.11 %
P/E (Cena vůči ziskům) 77.87
Forward P/E 0.29
EV/Sales 13.25
EV/EBITDA 43.33
EV/EBIT 46.66
PEG 4.15
Price/Sales 11.45
P/FCF 57.75
Price/Book 12.69
Účetní hodnota na akcii 20.07
Hotovost na akcii 2.05
FCF vůči ceně 1.73 %
Počet zaměstnanců 7,770
Tržba na zaměstnance 411.432k
Profit margin 14.84 %
Operating margin 28.27 %
Gross margin 57.53 %
EBIT margin 28.39 %
EBITDA margin 30.57 %
EPS - Zisk na akcii 3.27
EPS - Kvartální růst 1.50 %
EPS - Očekávaný růst příští rok 7.09 %
Return on assets 10.26 %
Return on equity 17.04 %
ROIC 19.49 %
ROCE 23.78 %
Dluhy/Equity 0.64
Čistý dluh/EBITDA 2.67
Current ratio 1.73
Quick Ratio 1.23
Volatilita 2.13
Beta 0.81
RSI 30.57
Cílová cena analytiků 193
Známka akcie (dle analytiků) 2.72
Insider ownership 0.80 %
Institutional ownership 69.79 %
Počet akcií 145.681M
Procento shortovaných akcií 0.82 %
Short ratio 1.59 %
Dividenda 1.59
Procentuální dividenda 0.62 %
Dividenda/Zisk 48.62 %
Obchodovaná od 1995
Země United States

Finanční výsledky akcie RMD

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$2,957.013$2,606.572$2,340.196$2,066.737$1,838.713$1,678.912
Cost Of Goods Sold$1,239.227$1,112.501$1,005.298$864.992$772.216$667.516
Gross Profit$1,717.786$1,494.071$1,334.898$1,201.745$1,066.497$1,011.396
Research And Development Expenses$201.946$180.651$155.149$144.467$118.651$114.865
SG&A Expenses$676.689$645.01$600.369$553.968$488.057$478.627
Other Operating Income Or Expenses$0.6$-47.322-$-18.576--
Operating Expenses$2,147.354$2,027.309$1,798.365$1,640.939$1,409.761$1,269.676
Operating Income$809.659$579.263$541.831$425.798$428.952$409.236
Total Non-Operating Income/Expense$-76.571$-60.416$-20.519$-7.055$10.614$26.68
Pre-Tax Income$733.088$518.847$521.312$418.743$439.566$435.916
Income Taxes$111.414$114.255$205.724$76.459$87.157$83.03
Income After Taxes$621.674$404.592$315.588$342.284$352.409$352.886
Other Income------
Income From Continuous Operations$621.674$404.592$315.588$342.284$352.409$352.886
Income From Discontinued Operations------
Net Income$621.674$404.592$315.588$342.284$352.409$352.886
EBITDA$991.032$730.058$661.791$537.955$515.801$482.292
EBIT$809.659$579.263$541.831$425.798$428.952$409.236
Basic Shares Outstanding144143143141140140
Shares Outstanding146144144142142143
Basic EPS$4.31$2.83$2.21$2.42$2.51$2.51
EPS - Earnings Per Share$4.27$2.80$2.19$2.40$2.49$2.47
# 2020 2019 2018 2017 2016 2015
Current Ratio2.52752.062.08454.56512.22535.2835
Long-term Debt / Capital0.3180.37790.11590.35490.34010.1592
Debt/Equity Ratio0.4710.61330.13670.55020.6920.1894
Gross Margin58.091957.319457.042158.14758.002460.2412
Operating Margin27.38122.223223.153220.602423.328924.3751
EBIT Margin27.38122.223223.153220.602423.328924.3751
EBITDA Margin33.514628.008428.279326.029228.052328.7265
Pre-Tax Profit Margin24.791519.905322.276420.261123.906225.9642
Net Profit Margin21.023715.52213.485516.561619.166121.0187
Asset Turnover0.64460.63460.76380.59590.56460.7695
Inventory Turnover Ratio2.97243.18183.74133.22373.44042.704
Receiveable Turnover6.234.93224.83834.58734.81234.6306
Days Sales In Receivables58.587774.00475.439779.566775.847378.8233
ROE - Return On Equity24.896619.524815.327417.461120.793222.2317
Return On Tangible Equity392.137-132.130740.728854.0228104.95327.6577
ROA - Return On Assets13.55189.849610.30019.868410.82116.1743
ROI - Return On Investment16.980312.146113.550611.263513.722218.692
Book Value Per Share17.234314.424814.430813.787712.049111.2996
Operating Cash Flow Per Share2.3308-0.33020.6008-0.96111.1822-0.0249
Free Cash Flow Per Share2.1519-0.37120.603-0.98471.20710.0408